News Prime Medicine, Inc.

Equities

PRME

US74168J1016

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 06:00:00 13/05/26 am AEST			5-day change	1st Jan Change
3.300 ^USD	+1.85%		-2.65%	-4.90%

08/05	Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI

All News

Mentions Relevance

08/05	Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
07/05	Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates	GL
17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI
16/04	Prime Medicine Names Svetlana Makhni CFO	MT
16/04	Prime Medicine, Inc. Announces Executive Changes, Effective April 16, 2026	CI
16/04	Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer	GL
19/03	Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
12/03	Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target	MT
07/03	Prime Medicine, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-04-2026 01:10 PM
04/03	Prime Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/03	Prime Medicine 2025 Net Loss Narrows as Revenue Rises -- Shares Fall Pre-Bell	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Total Revenue $4.6M, vs. FactSet Est of $5.7M	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Net Loss $1.35 a Share, vs. FactSet Est of $1.30 Loss	MT
04/03	Prime Medicine : March 2026 Corporate Presentation	PU
04/03	Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates	GL
03/03	Prime Medicine, Inc. Auditor Raises 'Going Concern' Doubt	CI
26/02	Prime Medicine to Participate in Upcoming Investor Conferences	GL
26/02	Prime Medicine to Participate in Upcoming Investor Conferences	AQ
15/01	Prime Medicine, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
08/01	Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference	GL
24/12	LifeSci Initiates Prime Medicine at Outperform With $6 Price Target	MT
22/12	Prime Medicine, Inc.(NasdaqGM:PRME) added to S&P Biotechnology Select Industry Index	CI
20/12	Prime Medicine, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 11:15 AM
08/12	Prime Medicine : Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease	PU
08/12	Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease	GL